Ginkgo Bioworks Holdings, Inc.

Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), sponsored by Eagle Equity Partners IV LLC with principals Harry Sloan, Jeff Sagansky, and Eli Baker, completed its initial public offering in 2021 as a blank-check company targeting the diversified sector. In May 2021, Soaring Eagle announced a business combination with Ginkgo Bioworks Holdings, Inc., a synthetic biology platform company. The transaction subsequently closed, transitioning Ginkgo Bioworks into the public markets. The SPAC is now listed as closed, marking the completion of the merger cycle for SRNG. Investors and analysts seeking full deal metrics, filing history, and comparable SPAC data on Soaring Eagle can sign up for access at SpacDesk.

SPAC Counterparty (1)